Maryland-based Novavax announced Monday it would be its phase 3 trial for its COVID-19 vaccine in the U.S. and Mexico.
Its the fifth company to begin a large-scale trial of the coronavirus vaccine in the U.S.
Novavax COVID-19 Vaccine Becomes 5th to Reach Phase 3 Trial in the US
Wibbitz Top Stories
Novavax COVID-19 Vaccine Becomes
5th to Reach Phase 3 Trial in the US.
On Monday, Novavax announced the beginning
of..
